ICM
SCSC icon

Invenomic Capital Management’s Scansource SCSC Stock Holding History

Invenomic Capital Management’s Portfolio SCSC Stock Details SCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-46,363
Closed -$1.71M – 167
2019
Q4 		$1.71M Buy
+46,363
New +$1.58M 0.69% 60

Other funds holding SCSC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invenomic Capital Management's SCSC Position: Q1 2020 in Review

Invenomic Capital Management sold out of Scansource (SCSC) in Q1 2020, closing a stake of 46,363 shares — an estimated $1.71M sold.

Invenomic Capital Management first reported a position in SCSC in Q4 2019 and held it in 1 quarter. The position peaked at $1.71M in Q4 2019. 143 funds tracked by Wall St. Rank hold SCSC as of Q1 2020.

  • Invenomic Capital Management reported no remaining Scansource position as of Q1 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 46,363 Scansource shares in Q1 2020, an estimated $1.71M.
  • Invenomic Capital Management first reported a position in Scansource in Q4 2019 and held it in 1 quarter.
  • Invenomic Capital Management's Scansource position peaked at $1.71M in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Scansource as of Q1 2020.

Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.